Oxford/AstraZeneca vaccine 80% effective against B1.617.2 variant of COVID-19: UK govt study



The Oxford/AstraZeneca two-dose vaccine is also being produced by the Serum Institute of India as Covishield and being administered among the adult population in India to protect against the deadly virus.